Childhood Pneumococcal Diseases and Serotypes: Can Vaccines Protect?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To describe pneumococcal diseases in pediatric intensive care unit (PICU) and non-PICU patients.
The clinical, serotypes, and antibacterial sensitivity patterns of all children admitted to the pediatric wards (including PICU) of a university-affiliated teaching hospital from 2007 through 2009 with pneumococcal isolates were reviewed.
Twelve cases of pneumococcal disease in children from 2007 through 2009 were reported. Five patients were admitted to PICU and 7 were general pediatric admissions. Four patients (2 PICU and 2 general pediatric) had received full or partial 7-valent pneumococcal vaccinations. All four patients recovered following systemic antibiotic treatment without sequelae. The serotypes of all PICU and some general pediatric cases were available and included 3, 6B, 19A and 19F. All isolates were sensitive to vancomycin. 50% were intermediate resistant/resistant to penicillin and 17% resistant to cefotaxime. PICU cases required longer total hospital stay (23 days vs 5 days, p = 0.013). Three patients were ventilated and one received inotropic support. There was no death in this series.
Pneumococcal disease may develop despite prior vaccination. The expanded coverage of newer polyvalent pneumococcal vaccines might have prevented some, but not all, of these admissions.
- Pneumococcal vaccines. WHO position paper. Weekly Epidemiological Record 1999; 74(23):177–83.
- Ip M, Chau SS, Chi F, Cheuk ES, Ma H, Lai RW, et al. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005. Antimicrob Agents Chemother. 2007;51(6):2192–4. CrossRef
- Ip M, Nelson EA, Cheuk ES, Sung RY, Li A, Ma H, et al. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong. J Clin Microbiol. 2007;45(6):1969–71. CrossRef
- Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med. 2001;345(16):1177–83. CrossRef
- Kyaw MH, Jones IG, Campbell H. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health. Acta Paediatr. 2001;90(5):473–6. CrossRef
- Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354(14):1455–63 [Erratum appears in N Engl J Med. 2006 Aug 10;355:638]. CrossRef
- Musher DM. Pneumococcal vaccine–direct and indirect (“herd”) effects. N Engl J Med. 2006;354(14):1522–4. CrossRef
- Morgenstern D, Garcia-Curiel CS. Clarifications about pneumococcal vaccines. Am J Health-Syst Pharm. 2010;67(3):183. CrossRef
- Ip M, Lyon DJ, Yung RW, Tsang L, Cheng AF. Introduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong Kong. J Clin Microbiol. 2002;40(4):1522–5. CrossRef
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Twentieth informational supplement, 20th ed. M100-S20. Clinical and Laboratory Standards Institute, Wayne, Pa.
- O’Halloran DM, Cafferkey MT. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol. 2005;43(7):3487–90. CrossRef
- Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772–8. CrossRef
- Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47(4):1012–20. CrossRef
- Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63(3):511–9. CrossRef
- Hon KL, Hung E, Tang J, Chow CM, Leung TF, Cheung KL, et al. Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit. Pediatr Pulmonol. 2008;43(3):275–80. CrossRef
- Hon KL, Leung AK. Severe childhood respiratory viral infections. Adv Pediatr. 2009;56(1):47–73. CrossRef
- Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol. 2010;39 Suppl 1:i172–85. CrossRef
- Childhood Pneumococcal Diseases and Serotypes: Can Vaccines Protect?
The Indian Journal of Pediatrics
Volume 77, Issue 12 , pp 1387-1391
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Invasive S pneumoniae, Septicemia
- Antibiotic resistance
- Industry Sectors
- Author Affiliations
- 1. Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, 6/F, Clinical Sciences Building, Shatin, Hong Kong
- 2. Department of Microbiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong
- 3. Department of Pharmacy, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong
- 4. Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong